Best diagnosticians: TOP 462 doctors

Dr. Victor Alexander Krol - Chief of Gastroenterology, Internal Medicine and Obesity Treatment Center at Martinus Hospital

Dr. Victor Alexander Krol is a highly qualified specialist, heading the departments of gastroenterology and internal medicine. With many years of experience and deep knowledge in his field, Dr. Krol has established himself as an outstanding expert, providing patients with comprehensive treatment and an individual approach. He actively uses the latest methods of diagnosis and treatment of diseases of the gastrointestinal tract, metabolism, as well as diseases of the cardiovascular and respiratory systems.

Dr. Krol is also the director of the certified Obesity Treatment Center at Martinus Hospital, which provides surgical and endoscopic treatments for obesity. The center uses advanced technology to diagnose and treat obesity (adiposis), including methods such as bariatric surgery, endoscopic weight loss, and specialized programs for patients with different stages of obesity. The center is certified to high standards and has excellent results in the treatment of this serious disease.

The Gastroenterology Department, headed by Dr. Krol, diagnoses and treats diseases of the stomach, intestines, liver, pancreas, and gallbladder. The doctors of the department use a wide range of methods, including endoscopic procedures, ultrasound, and other modern diagnostic technologies.

The Department of Internal Medicine covers a wide range of diseases, including cardiology, diabetology, infectology, and therapy of respiratory and renal diseases. Dr. Krol and his team provide a comprehensive approach to treatment using the most advanced methods of medicine.

Thanks to his high professionalism and humane approach to each patient, Dr. Krol deservedly enjoys the respect of colleagues and patients.

Professor Markus Dukes is a specialist in diagnostic radiology and minimally invasive therapy.

Awards

• Gold Medal of Honorary Professor of Osaka Medical University (Japan).
• Honorary member of DeGIR (German Society for Interventional Radiology and Minimally Invasive Therapy).

Education and professional experience

• 1982-1988 - study of human medicine at the Johannes-Gutenberg University in Mainz.
• 1988 - approval and medical license.
• 1988-1989 - Medical officer of the Bundeswehr.
• 1990 - Candidate of Medical Sciences in the field of radiology, subject: “Investigation of the influence of dilation speed on its success, as well as on damage to the vessel walls during balloon expansion”, at the Johannes-Gutenberg University in Mainz.
• 1990-1996 - Resident in the Department of Radiology at the Ruprecht-Karls University.
• 1996 - Senior physician in the Department of Radiodiagnostics at the Ruprecht-Karls University of Heidelberg.
• 1998 - Doctorate in Diagnostic Radiology, topic: "Direct comparison of imaging methods for gastric carcinoma: the importance of optimized examination methods in clinical practice and first experience with magnetic resonance imaging."
• 2000 - Deputy Head of the Department of Radiology, Department of Radiodiagnostics at the Ruprecht-Karls University of Heidelberg.
• 2000-2002 - Head of the Image Processing Center at the Orthopedic Clinic of the University of Heidelberg.
• 2002-2003 - Head of the Department of Radiology, Surgical Clinic, Department of Radiology at the Ruprecht-Karls University of Heidelberg.
• 2003 - Chief Physician of the Central Institute of Radiology and Neuroradiology at the Nordwest Clinic in Frankfurt am Main.
• 2006 - Associate Professor in the Department of Radiology at the University of Heidelberg.

Scientific activity

Marcus Dukes is one of the first physicians to perform minimally invasive microwave ablation of liver and lung tumors under CT guidance.

Clinical activities

The professor heads the first and only MRI-guided FUS ablation center in the Rhine-Main region. In most cases, the procedure allows avoiding surgical intervention. Patients of the center have access to ablation for prostate cancer, bone and liver metastases, benign tumors, and treatment of uterine fibroids without surgery.

Membership in organizations

• DRG (German Society of Radiologists).
• DeGIR (German Society for Interventional Radiology and Minimally Invasive Therapy).
• RSNA (Radiological Society of North America).
• ESGAR (European Society of Gastrointestinal and Abdominal Radiology).
• CIRSE (Cardiovascular and Interventional Radiology Society of Europe).
• ECR (European Congress of Radiology).
• EUFUS (European FUS Society).
• MEDICA (German Society for Interdisciplinary Medicine).

Membership in societies:

Expert of scientific journals 

Close co-operation with leading surgeons

Membership of the German Medical Association 

Specialities:

Introduction of new and modern techniques in the field of oncological surgery
General and visceral surgery

Minimally invasive surgery

Gastrointestinal oncology surgery

Oncological surgery

Haemorrhoids treatment

Additional clinical specialisation in minimally invasive and hernia surgery

Surgery and transplantation of the pancreas

Work Experience:

2005: Specialist in the field of surgery

2008: Appointed Senior Consultant specialising in pancreatic surgery and transplantation

2010: Coordinator of the Pancreatic Cancer Centre (Oncocert)

2013: Specialist in visceral surgery

2014: Managing Senior Physician, additional clinical specialisation in minimally invasive and hernia surgery

2019: Chief Surgeon of the Colorectal Cancer Centre Bochum (the first certified colorectal cancer centre in Germany and one of the first certified leading colorectal centres in Europe)

2021: Chief Surgeon of the Department of Surgery at the Academic Hospital Solingen

Thanks to the professor and his team, the department has been modernised by introducing modern surgical methods of treatment and especially improved methods of post-operative recovery. The Department of Surgery at the Solingen Clinic is now further expanding its focus on minimally invasive surgery in the direction of robotics. The clinic has allocated a huge budget for the purchase of state-of-the-art equipment in order to offer patients a full range of surgical methods for the treatment of benign and malignant diseases of the oesophagus, lungs, stomach, liver, pancreas and intestines according to current guidelines and using the most modern technical equipment.

Professor Schenker is an active researcher and lecturer. He lectures at medical universities and organises seminars and workshops for colleagues. He cooperates closely with the Cancer Centre, the Pancreatic Cancer Treatment Centre, the Intestinal Cancer Treatment Centre and the Interregional Trauma Centre.

EDUCATION:

2000 - SSK Okmeydanı Training and Research Hospital, .

1996 - Istanbul University, Istanbul Faculty of Medicine

EXPERIENCE:

2019 - Istanbul Medipol University Pendik Hospital

2017 - 2019 - Private Adatıp Kurtköy Hospital

2005 - 2017 - Private Avicenna Umut Hospital

2003 - 2005 - SSK Yalova Regional Hospital

2002 - 2003 - Kayseri Military Hospital

EDUCATION:

2015

Uludag University, Ophthalmology

2008

Eskisehir Osmangazi University, Faculty of Medicine

2001

Kırıkkale Science High School, Numerical

EXPERIENCE:

2019 Gazi University Faculty of Medicine Ophthalmology (Vitreo-Retinal Surgery and Medical Retina Fellowship)

2016 SBÜ Zekai Tahir Burak EAH (Retinopathy of Prematurity Fellowship)/

2015 - 2023 Kocaeli Derince Training and Research Hospital

2023 - Medipol University Pendik Hospital

Education:

• Degree: Faculty of Medicine, Trakya University, 2009
• Medical Specialty: Internal Medicine, Bakırköy Dr. Sadi Konuk Training and Research Hospital, 2010-2014
• Specialist Doctor: Internal Medicine, Kanuni Sultan Süleyman Training and Research Hospital, 2014-2019
• Specialist Doctor: Internal Medicine, Turkish Hospital Internal Medicine Clinic, Qatar, 2019-2020
• Specialist Doctor: Internal Medicine, Istanbul Medipol University Hospital Mega Hospital Internal Medicine Department, 2020-2024
• Associate Professor Doctor: Internal Medicine, Istanbul Medipol University Medipol Acıbadem Regional Hospital, 2024-Present.

Roles in Projects:

Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.

Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.

Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.

Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).

Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.

• AREAS OF INTEREST
• Spine surgery
• Scoliosis
• Kyphosis
• Childhood spinal diseases
• Degenerative spine diseases
• Lumbar cervical disc herniation
• Knee hip joint disorders
• Orthopedic trauma surgery

• Education and Specialization
• 2010 - Cerrahpasa Faculty of Medicine - Medical Education
• 2016 - Medeniyet University Goztepe Training and Research Hospital - Specialization

• Experience
• 2016 - 2022 - Sisli Hamidiye Etfal Training and Research Hospital
• 2015 -2016 - Chicago Loyola University, Illinois, USA

• Courses and Certificates
• 13.12.2019-14.12.2019 Turkish Spine Society Eurospine Accredited Education Modules
• 08.11.2019-10.11.2019 Turkish Spine Society Eurospine Accredited Education Modules
• 31.08.2015-04.09.2015 Basic Microsurgery Course, MICROSURGERY EDUCATION-RESEARCH LABORATORY
• AO Trauma Course-Basic Principles of Fracture Management
• 07.06.2014-10.06.2014 Fracture Management, Kodi Kojima Chairperson AOTrauma Education Commission
• 01.03.2013-02.03.2013 Instrumentation in Arthroscopic Surgery

• Professional Memberships
• Turkish Orthopedics and Traumatology Association (TOTBİD)
• Turkish Medical Association - Istanbul Medical Chamber

Education

MSc Faculty of Medicine (ING) Hacettepe University 1991-1997
Specialization Department of Pediatrics Dicle Universityniversitesi 1997-2002
Minor Cerrahpaşa Faculty of Medicine Pediatric Hematology & Oncology Department Istanbul University 2006-2009
Bone Marrow Transplant Unit MP Göztepe Hospital 2012-2013

Experience

Assistant Professor
Afyon Kocatepe University/Faculty of Medicine/Internal Medical Sciences
2003-2009 Department/ÇDepartment of Pediatrics)

Assistant Professor
Istanbul University/Cerrahpaşa Faculty of Medicineltesi/Internal Medical Sciences
2006-2009 Department of Pediatrics)

Pediatric Hematology Specialist Diyarbakır Children's Hospital, Pediatric Hematology compulsory service 2009-2012
Transfer Ünitesi Assistant Hematology Specialist Private Medical Park Göztepe Hospital Bone Marrow Transplant Unit Assistant Responsible Pediatric Hematology Specialist
2012-2013

Assistant Professor
Akdeniz University / Faculty of Medicine / Department of Internal Medical Scienceslümü/Department of Pediatrics)
2013-2014

Assistant Professor Marmara University/Faculty of Medicine/Department of Internal Medical Sciences/Department of Pediatrics) 2014-2024

Scientific Memberships

Turkish Society of Hematology
Turkish Pediatric Hematology Association
Marmara Pediatric Association
Turkish Pediatric Society
Istanbul Medical Chamber
EBMT (European Bone Marrow Transplantation)

Dr. Luis Padilla is a physician who specializes in gynecologic oncology, general practice, and healthcare administration. He helped introduce the da Vinci Robotic Assisted Surgical System, which improved minimally invasive surgery.

Dr. Padilla has worked as Associate Administrator for Health Workforce at HRSA. He also served as Director of the NHSC. In these roles, he influenced national health policy and workforce training. He has received the People’s Choice Award and the People Living Through Cancer Award for his commitment to patient care.

He served on the National Advisory Council of the NHSC from 2007 to 2010. He earned degrees from UC Irvine, Wake Forest, Brown, Northwestern, and the University of Minnesota.

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Dr. Levent Dalar is a respected pulmonologist with over 20 years of experience. He specializes in interventional bronchoscopy and rare lung diseases. Dr. Dalar has trained and worked in France, Switzerland, and Turkey. He gained valuable experience at the University of Zürich’s Lung Transplant Unit. His background gives him a broad view of advanced lung care.

Dr. Dalar is known for his work in bronchoscopic techniques. He has diagnosed and treated thousands of complex respiratory cases. His main focus is on interstitial lung diseases and respiratory deficiencies. As a professor, he helps train future specialists at top universities. He is also an active member of ERS, EABIP, SPLF, and GELF, staying involved in the latest developments in respiratory medicine.

Education:

• -Degree in Human Nutrition and Dietetics.
• -Degree in Exercise and Sport Sciences.
• -University specialization in the topic of intestinal microbiota.
• - Specialization in the field of sports enterprise management.
• - Certified Athletic Trainer (RFEA).
• -Qualifications of the Federation of Spanish Personal Trainers and Fitness (FEEPYF):
  • -Functional training.
  • -High intensity interval training (HIIT).
  • -Crossfit.
  • -Training using suspension systems.

Professional experience:

• -Researcher in the Exercise Physiology Laboratory in the team of the University Alfonso X El Sage.
• -Consultant and sports nutrition coach.
• -Dietitian in the nephrology department of the Fuensanta clinic.
• -Organization and holding of sporting events in the Spanish Olympic Committee.
• -Personal trainer.

Education and Specialization

• Hacettepe University Faculty of Medicine – English Medical Education
• Akdeniz University Faculty of Medicine – Internal Medicine – Residency
• Akdeniz University Hospital – Nephrology – Subspecialty Training
• San Bortolo Hospital, Vicenza, Italy – Critical Care Nephrology and Transplantation – Fellowship
• Hacettepe University Faculty of Medicine – Associate Professorship

Professional Memberships

1. Turkish Society of Nephrology (TND)
2. European Society of Nephrology (ERA-EDTA)
3. Middle East Society of Organ Transplantation (MESOT)
4. International Society of Nephrology (ISN)

Experience

1989 - 1990

Diyarbakır Kulp Merkez Sağlık Ocağı

1990

Selçuk University Faculty of Medicine

1995

Konya State Hospital

1995

Selçuk University Faculty of Medicine

1997

600-Bed Golcuk Naval Hospital

1999

Selçuk University Meram Faculty of Medicine

2005

Selçuk University Meram Faculty of Medicine

2011

Selçuk University Selçuklu Faculty of Medicine

2020

Özel Bower Hospital

Education

1994 Selçuk University, Thoracic Surgery

1989 Gazi University, Faculty of Medicine

1989 Gazi University, Faculty of Medicine

Education

• Undergraduate: Istanbul Faculty of Medicine, Istanbul University, 2007
• MSc (Internal Medicine Department): Marmara University Faculty of Medicine, 2012
• PhD (Hematology Clinic): Istanbul Training and Research Hospital, 2018
• Associate Professor (Hematology Clinic): Prof.Dr.Cemil Tascioglu Training and Research Hospital, 2019

Prof. Dr. Rafet Eren graduated from Istanbul Faculty of Medicine in 2007. He completed his Internal Medicine specialty training at Marmara University Faculty of Medicine in 2012. In 2018, he became a Hematology subspecialist at Istanbul Training and Research Hospital. In 2019, he was awarded the title of Associate Professor in the field of Hematology. Afterwards, he worked as a faculty member at Başakşehir Çam and Sakura City Hospital, Bozyaka Training and Research Hospital and Istinye University (Istinye University Bahçeşehir and Liv Hospital Vadistanbul) and is currently working at Biruni University Hospital. Dr. Rafet Eren is a member of Turkish Society of Hematology, Hematology Specialty Society and European Society of Hematology and speaks English fluently. He has around 50 publications in national and international refereed journals.

Scientific Memberships

• Turkish Hematology Association
• Hematology Specialty Society
• Turkish Internal Medicine Specialty Society
• European Society of Hematology
•  

Awards 

• Young Researcher Award (42nd National Hematology Congress), 2016
• Special Jury Paper Award (3rd Hematologic Oncology Congress), 2015
• Paper 3rd Prize (2nd Hematologic Oncology and Bone Marrow Transplantation Symposium), 2016